{"transactions":[{"id":721199,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-01T20:33:41.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1905,"price":11.15,"value":21240.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2026 through June 30, 2026.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 1, 2026."}],"balance_after":203227,"source":{"system":"sec-edgar","filing":"0001997032-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000199703226000006/primarydocument.xml","form_type":"4"}},{"id":721198,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33977,"kind":"person","name":"Leonard Frank X","position":1,"cik":"0001822879","reported_name":"Leonard Frank X","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-01T20:30:40.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1905,"price":11.15,"value":21240.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2026 through June 30, 2026.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 1, 2026."}],"balance_after":461425,"source":{"system":"sec-edgar","filing":"0001822879-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182287926000006/primarydocument.xml","form_type":"4"}},{"id":721197,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-07-01T20:30:27.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1299,"price":11.15,"value":14483.85,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2026 through June 30, 2026.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 1, 2026."}],"balance_after":243752,"source":{"system":"sec-edgar","filing":"0001917165-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000191716526000006/primarydocument.xml","form_type":"4"}},{"id":721196,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33975,"kind":"person","name":"Danziger Asaf","position":1,"cik":"0001654435","reported_name":"Danziger Asaf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-07-01T20:30:08.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":268,"price":11.15,"value":2988.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2026 through June 30, 2026.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 1, 2026."}],"balance_after":416742,"source":{"system":"sec-edgar","filing":"0001654435-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000165443526000003/primarydocument.xml","form_type":"4"}},{"id":747913,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33977,"kind":"person","name":"Leonard Frank X","position":1,"cik":"0001822879","reported_name":"Leonard Frank X","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-05T20:28:00.000Z","date":"2026-06-04","kind":"sale","planned":false,"acquired":false,"shares":34273,"price":17.9335,"value":614634.8455,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $17.665 USD to $18.37 USD; the price reported above reflects the weighted average sale price."}],"balance_after":459520,"source":{"system":"sec-edgar","filing":"0001822879-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182287926000004/primarydocument.xml","form_type":"4"}},{"id":747911,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40921,"kind":"person","name":"LEUNG GABRIEL","position":1,"cik":"0001236183","reported_name":"LEUNG GABRIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:27:42.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":16999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":16999,"derivative":{"exercise_price":16.15,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Ordinary Shares","underlying_shares":16999},"source":{"system":"sec-edgar","filing":"0001236183-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000123618326000002/primarydocument.xml","form_type":"4"}},{"id":747910,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40921,"kind":"person","name":"LEUNG GABRIEL","position":1,"cik":"0001236183","reported_name":"LEUNG GABRIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-05T20:27:42.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":11610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":101109,"source":{"system":"sec-edgar","filing":"0001236183-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000123618326000002/primarydocument.xml","form_type":"4"}},{"id":748278,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":41004,"kind":"person","name":"Stafford Kristin","position":1,"cik":"0001970438","reported_name":"Stafford Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:27:29.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":16999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":16999,"derivative":{"exercise_price":16.15,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Ordinary Shares","underlying_shares":16999},"source":{"system":"sec-edgar","filing":"0001970438-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1970438/000197043826000002/primarydocument.xml","form_type":"4"}},{"id":748277,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":41004,"kind":"person","name":"Stafford Kristin","position":1,"cik":"0001970438","reported_name":"Stafford Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-05T20:27:29.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":11610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":22934,"source":{"system":"sec-edgar","filing":"0001970438-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1970438/000197043826000002/primarydocument.xml","form_type":"4"}},{"id":747909,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40920,"kind":"person","name":"Ocean Allyson J","position":1,"cik":"0001967326","reported_name":"Ocean Allyson J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:27:08.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":16999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":16999,"derivative":{"exercise_price":16.15,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Ordinary Shares","underlying_shares":16999},"source":{"system":"sec-edgar","filing":"0001967326-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000196732626000002/primarydocument.xml","form_type":"4"}},{"id":747908,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40920,"kind":"person","name":"Ocean Allyson J","position":1,"cik":"0001967326","reported_name":"Ocean Allyson J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-05T20:27:08.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":11610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":22934,"source":{"system":"sec-edgar","filing":"0001967326-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000196732626000002/primarydocument.xml","form_type":"4"}},{"id":747907,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":15597,"kind":"person","name":"Scannell Timothy J","position":1,"cik":"0001451533","reported_name":"Scannell Timothy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:26:54.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":16999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":16999,"derivative":{"exercise_price":16.15,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Ordinary Shares","underlying_shares":16999},"source":{"system":"sec-edgar","filing":"0001451533-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000145153326000002/primarydocument.xml","form_type":"4"}},{"id":747906,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":15597,"kind":"person","name":"Scannell Timothy J","position":1,"cik":"0001451533","reported_name":"Scannell Timothy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-05T20:26:54.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":11610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":25898,"source":{"system":"sec-edgar","filing":"0001451533-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000145153326000002/primarydocument.xml","form_type":"4"}},{"id":747905,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":29474,"kind":"person","name":"HILLEMAN JERYL L","position":1,"cik":"0001216628","reported_name":"HILLEMAN JERYL L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:26:36.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":16999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":16999,"derivative":{"exercise_price":16.15,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Ordinary Shares","underlying_shares":16999},"source":{"system":"sec-edgar","filing":"0001216628-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000121662826000002/primarydocument.xml","form_type":"4"}},{"id":747904,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":29474,"kind":"person","name":"HILLEMAN JERYL L","position":1,"cik":"0001216628","reported_name":"HILLEMAN JERYL L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-05T20:26:36.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":11610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":25471,"source":{"system":"sec-edgar","filing":"0001216628-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000121662826000002/primarydocument.xml","form_type":"4"}},{"id":747903,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:26:21.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":16999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":16999,"derivative":{"exercise_price":16.15,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Ordinary Shares","underlying_shares":16999},"source":{"system":"sec-edgar","filing":"0001310880-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000131088026000006/primarydocument.xml","form_type":"4"}},{"id":747902,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-05T20:26:21.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":11610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":32075,"source":{"system":"sec-edgar","filing":"0001310880-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000131088026000006/primarydocument.xml","form_type":"4"}},{"id":747901,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:26:06.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":16999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":16999,"derivative":{"exercise_price":16.15,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Ordinary Shares","underlying_shares":16999},"source":{"system":"sec-edgar","filing":"0001696864-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000169686426000001/primarydocument.xml","form_type":"4"}},{"id":747900,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-05T20:26:06.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":11610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":30284,"source":{"system":"sec-edgar","filing":"0001696864-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000169686426000001/primarydocument.xml","form_type":"4"}},{"id":747899,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40917,"kind":"person","name":"VERNON W ANTHONY","position":1,"cik":"0001369091","reported_name":"VERNON W ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:25:46.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":16999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":16999,"derivative":{"exercise_price":16.15,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Ordinary Shares","underlying_shares":16999},"source":{"system":"sec-edgar","filing":"0001369091-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000136909126000005/primarydocument.xml","form_type":"4"}},{"id":747898,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40917,"kind":"person","name":"VERNON W ANTHONY","position":1,"cik":"0001369091","reported_name":"VERNON W ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-05T20:25:46.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":11610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":209267,"source":{"system":"sec-edgar","filing":"0001369091-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000136909126000005/primarydocument.xml","form_type":"4"}},{"id":751703,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40921,"kind":"person","name":"LEUNG GABRIEL","position":1,"cik":"0001236183","reported_name":"LEUNG GABRIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-03T20:54:07.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":2945,"price":15.7707,"value":46444.7115,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price."}],"balance_after":89499,"source":{"system":"sec-edgar","filing":"0001236183-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000123618326000001/primarydocument.xml","form_type":"4"}},{"id":752207,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":41004,"kind":"person","name":"Stafford Kristin","position":1,"cik":"0001970438","reported_name":"Stafford Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-03T20:53:56.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":2945,"price":15.7707,"value":46444.7115,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price."}],"balance_after":11324,"source":{"system":"sec-edgar","filing":"0001970438-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1970438/000197043826000001/primarydocument.xml","form_type":"4"}},{"id":751702,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40920,"kind":"person","name":"Ocean Allyson J","position":1,"cik":"0001967326","reported_name":"Ocean Allyson J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-03T20:53:42.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":2945,"price":15.7707,"value":46444.7115,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price."}],"balance_after":11324,"source":{"system":"sec-edgar","filing":"0001967326-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000196732626000001/primarydocument.xml","form_type":"4"}},{"id":751701,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":15597,"kind":"person","name":"Scannell Timothy J","position":1,"cik":"0001451533","reported_name":"Scannell Timothy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-03T20:53:19.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":2945,"price":15.7707,"value":46444.7115,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price."}],"balance_after":14288,"source":{"system":"sec-edgar","filing":"0001451533-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000145153326000001/primarydocument.xml","form_type":"4"}},{"id":751700,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":29474,"kind":"person","name":"HILLEMAN JERYL L","position":1,"cik":"0001216628","reported_name":"HILLEMAN JERYL L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-03T20:53:03.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":2945,"price":15.7707,"value":46444.7115,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price."}],"balance_after":13861,"source":{"system":"sec-edgar","filing":"0001216628-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000121662826000001/primarydocument.xml","form_type":"4"}},{"id":751699,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40917,"kind":"person","name":"VERNON W ANTHONY","position":1,"cik":"0001369091","reported_name":"VERNON W ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-03T20:52:48.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":2945,"price":15.7707,"value":46444.7115,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price."}],"balance_after":197657,"source":{"system":"sec-edgar","filing":"0001369091-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000136909126000004/primarydocument.xml","form_type":"4"}},{"id":751695,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-03T20:52:31.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":2945,"price":15.7707,"value":46444.7115,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price."}],"balance_after":20465,"source":{"system":"sec-edgar","filing":"0001310880-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000131088026000005/primarydocument.xml","form_type":"4"}},{"id":798823,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40917,"kind":"person","name":"VERNON W ANTHONY","position":1,"cik":"0001369091","reported_name":"VERNON W ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-28T20:27:46.000Z","date":"2026-04-28","kind":"exercise","planned":false,"acquired":false,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":11.39,"exercise_date":"2017-05-04","expiration_date":"2026-05-04","underlying":"Ordinary Shares","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001369091-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000136909126000002/primarydocument.xml","form_type":"4"}},{"id":798822,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40917,"kind":"person","name":"VERNON W ANTHONY","position":1,"cik":"0001369091","reported_name":"VERNON W ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-04-28T20:27:46.000Z","date":"2026-04-28","kind":"exercise","planned":false,"acquired":true,"shares":21500,"price":11.39,"value":244885.0,"ownership":{"direct":true},"balance_after":200602,"source":{"system":"sec-edgar","filing":"0001369091-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000136909126000002/primarydocument.xml","form_type":"4"}},{"id":858325,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62546,"kind":"person","name":"Leupin Nicolas","position":1,"cik":"0002007766","reported_name":"Leupin Nicolas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:33:41.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":1100,"price":13.3054,"value":14635.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price."}],"balance_after":102979,"source":{"system":"sec-edgar","filing":"0002007766-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000200776626000003/primarydocument.xml","form_type":"4"}},{"id":858324,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:33:25.000Z","date":"2026-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":17638,"price":13.3,"value":234585.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":422570,"source":{"system":"sec-edgar","filing":"0001822014-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182201426000003/primarydocument.xml","form_type":"4"}},{"id":858323,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T21:32:48.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":73340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date."}],"balance_after":73340,"derivative":{"exercise_price":13.3,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":73340},"source":{"system":"sec-edgar","filing":"0001917165-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000191716526000004/primarydocument.xml","form_type":"4"}},{"id":858322,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:32:48.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":50125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal  parts on the first, second and third  anniversary of the grant date, subject to the reporting person's continued employment through such dates."}],"balance_after":242453,"source":{"system":"sec-edgar","filing":"0001917165-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000191716526000004/primarydocument.xml","form_type":"4"}},{"id":858321,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62544,"kind":"person","name":"Brackmann Christoph","position":1,"cik":"0002048634","reported_name":"Brackmann Christoph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T21:31:55.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":80674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date."}],"balance_after":80674,"derivative":{"exercise_price":13.3,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":80674},"source":{"system":"sec-edgar","filing":"0002048634-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000204863426000001/primarydocument.xml","form_type":"4"}},{"id":858320,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62544,"kind":"person","name":"Brackmann Christoph","position":1,"cik":"0002048634","reported_name":"Brackmann Christoph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:31:55.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":6412,"price":13.3054,"value":85314.2248,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price."}],"balance_after":182842,"source":{"system":"sec-edgar","filing":"0002048634-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000204863426000001/primarydocument.xml","form_type":"4"}},{"id":858319,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62544,"kind":"person","name":"Brackmann Christoph","position":1,"cik":"0002048634","reported_name":"Brackmann Christoph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:31:55.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":55137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal  parts on the first, second and third  anniversary of the grant date, subject to the reporting person's continued employment through such dates."}],"balance_after":189254,"source":{"system":"sec-edgar","filing":"0002048634-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000204863426000001/primarydocument.xml","form_type":"4"}},{"id":858318,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33977,"kind":"person","name":"Leonard Frank X","position":1,"cik":"0001822879","reported_name":"Leonard Frank X","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T21:31:35.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":216388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date."}],"balance_after":216388,"derivative":{"exercise_price":13.3,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":216388},"source":{"system":"sec-edgar","filing":"0001822879-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182287926000003/primarydocument.xml","form_type":"4"}},{"id":858317,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33977,"kind":"person","name":"Leonard Frank X","position":1,"cik":"0001822879","reported_name":"Leonard Frank X","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:31:35.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":5607,"price":13.3054,"value":74603.3778,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price."}],"balance_after":493793,"source":{"system":"sec-edgar","filing":"0001822879-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182287926000003/primarydocument.xml","form_type":"4"}},{"id":858316,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33977,"kind":"person","name":"Leonard Frank X","position":1,"cik":"0001822879","reported_name":"Leonard Frank X","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:31:35.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal  parts on the first, second and third  anniversary of the grant date, subject to the reporting person's continued employment through such dates."}],"balance_after":499400,"source":{"system":"sec-edgar","filing":"0001822879-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182287926000003/primarydocument.xml","form_type":"4"}},{"id":858315,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T21:31:04.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":58672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date."}],"balance_after":58672,"derivative":{"exercise_price":13.3,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":58672},"source":{"system":"sec-edgar","filing":"0001997032-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000199703226000004/primarydocument.xml","form_type":"4"}},{"id":858314,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:31:04.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":1100,"price":13.3054,"value":14635.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price."}],"balance_after":201322,"source":{"system":"sec-edgar","filing":"0001997032-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000199703226000004/primarydocument.xml","form_type":"4"}},{"id":858313,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:31:04.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":40100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal  parts on the first, second and third  anniversary of the grant date, subject to the reporting person's continued employment through such dates."}],"balance_after":202422,"source":{"system":"sec-edgar","filing":"0001997032-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000199703226000004/primarydocument.xml","form_type":"4"}},{"id":858312,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T21:30:44.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":30072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date."}],"balance_after":288517,"derivative":{"exercise_price":13.3,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":30072},"source":{"system":"sec-edgar","filing":"0001194459-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000119445926000001/primarydocument.xml","form_type":"4"}},{"id":858311,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T21:30:44.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":258445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date."}],"balance_after":258445,"derivative":{"exercise_price":13.3,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":258445},"source":{"system":"sec-edgar","filing":"0001194459-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000119445926000001/primarydocument.xml","form_type":"4"}},{"id":858310,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:30:44.000Z","date":"2026-03-03","kind":"sale","planned":false,"acquired":false,"shares":21330,"price":13.4288,"value":286436.304,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Performance-Based Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $13.35 USD to $13.52 USD; the price reported above reflects the weighted average sale price."}],"balance_after":328397,"source":{"system":"sec-edgar","filing":"0001194459-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000119445926000001/primarydocument.xml","form_type":"4"}},{"id":858309,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:30:44.000Z","date":"2026-03-03","kind":"sale","planned":false,"acquired":false,"shares":50557,"price":12.7865,"value":646447.0805,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Performance-Based Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $12.299 USD to $13.277 USD; the price reported above reflects the weighted average sale price."}],"balance_after":349727,"source":{"system":"sec-edgar","filing":"0001194459-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000119445926000001/primarydocument.xml","form_type":"4"}},{"id":858308,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:30:44.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":200284,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents vesting of performance-based restricted stock units."}],"balance_after":400284,"source":{"system":"sec-edgar","filing":"0001194459-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000119445926000001/primarydocument.xml","form_type":"4"}},{"id":858307,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:30:44.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal  parts on the first, second and third  anniversary of the grant date, subject to the reporting person's continued employment through such dates."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001194459-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000119445926000001/primarydocument.xml","form_type":"4"}},{"id":858733,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Medical and Innovation Ofr"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T16:32:22.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":73340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date."}],"balance_after":73340,"derivative":{"exercise_price":13.3,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":73340},"source":{"system":"sec-edgar","filing":"0001811030-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000181103026000003/primarydocument.xml","form_type":"4"}},{"id":858732,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Medical and Innovation Ofr"}}],"security":"Ordinary Shares","published_at":"2026-03-05T16:32:22.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":6412,"price":13.3054,"value":85314.2248,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price."}],"balance_after":267190,"source":{"system":"sec-edgar","filing":"0001811030-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000181103026000003/primarydocument.xml","form_type":"4"}},{"id":858731,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Medical and Innovation Ofr"}}],"security":"Ordinary Shares","published_at":"2026-03-05T16:32:22.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":50125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal  parts on the first, second and third  anniversary of the grant date, subject to the reporting person's continued employment through such dates."}],"balance_after":273602,"source":{"system":"sec-edgar","filing":"0001811030-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000181103026000003/primarydocument.xml","form_type":"4"}},{"id":859036,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T16:31:19.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":58488,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date."}],"balance_after":66006,"derivative":{"exercise_price":13.3,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":58488},"source":{"system":"sec-edgar","filing":"0002039078-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907826000005/primarydocument.xml","form_type":"4"}},{"id":859035,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T16:31:19.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":7518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date."}],"balance_after":7518,"derivative":{"exercise_price":13.3,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":7518},"source":{"system":"sec-edgar","filing":"0002039078-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907826000005/primarydocument.xml","form_type":"4"}},{"id":859034,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T16:31:19.000Z","date":"2026-03-05","kind":"sale","planned":false,"acquired":false,"shares":43246,"price":13.774,"value":595670.404,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $13.74 USD to $14.07 USD; the price reported above reflects the weighted average sale price."}],"balance_after":72832,"source":{"system":"sec-edgar","filing":"0002039078-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907826000005/primarydocument.xml","form_type":"4"}},{"id":859033,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T16:31:19.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":5377,"price":13.3054,"value":71543.1358,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price."}],"balance_after":116078,"source":{"system":"sec-edgar","filing":"0002039078-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907826000005/primarydocument.xml","form_type":"4"}},{"id":859032,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T16:31:19.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":45112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal  parts on the first, second and third  anniversary of the grant date, subject to the reporting person's continued employment through such dates."}],"balance_after":121455,"source":{"system":"sec-edgar","filing":"0002039078-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907826000005/primarydocument.xml","form_type":"4"}},{"id":867069,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:10:24.000Z","date":"2026-02-27","kind":"sale","planned":false,"acquired":false,"shares":1441,"price":13.6638,"value":19689.5358,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.45 USD to $13.97 USD; the price reported above reflects the weighted average sale price."}],"balance_after":162322,"source":{"system":"sec-edgar","filing":"0001997032-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000199703226000003/primarydocument.xml","form_type":"4"}},{"id":867067,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62546,"kind":"person","name":"Leupin Nicolas","position":1,"cik":"0002007766","reported_name":"Leupin Nicolas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:09:55.000Z","date":"2026-02-27","kind":"sale","planned":false,"acquired":false,"shares":1029,"price":13.6638,"value":14060.0502,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.45 USD to $13.97 USD; the price reported above reflects the weighted average sale price."}],"balance_after":104079,"source":{"system":"sec-edgar","filing":"0002007766-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000200776626000002/primarydocument.xml","form_type":"4"}},{"id":867066,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33977,"kind":"person","name":"Leonard Frank X","position":1,"cik":"0001822879","reported_name":"Leonard Frank X","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:09:33.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":7232,"price":13.493,"value":97581.376,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $13.3126 USD to $13.70 USD; the price reported above reflects the weighted average sale price."}],"balance_after":349400,"source":{"system":"sec-edgar","filing":"0001822879-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182287926000002/primarydocument.xml","form_type":"4"}},{"id":867065,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33977,"kind":"person","name":"Leonard Frank X","position":1,"cik":"0001822879","reported_name":"Leonard Frank X","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:09:33.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":18621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents vesting of performance-based restricted stock units."}],"balance_after":356632,"source":{"system":"sec-edgar","filing":"0001822879-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182287926000002/primarydocument.xml","form_type":"4"}},{"id":867064,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33977,"kind":"person","name":"Leonard Frank X","position":1,"cik":"0001822879","reported_name":"Leonard Frank X","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:09:33.000Z","date":"2026-02-27","kind":"sale","planned":false,"acquired":false,"shares":9734,"price":13.6638,"value":133003.4292,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.45 USD to $13.97 USD; the price reported above reflects the weighted average sale price."}],"balance_after":338011,"source":{"system":"sec-edgar","filing":"0001822879-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182287926000002/primarydocument.xml","form_type":"4"}},{"id":867063,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:09:18.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":7228,"price":13.67,"value":98806.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":440208,"source":{"system":"sec-edgar","filing":"0001822014-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182201426000002/primarydocument.xml","form_type":"4"}},{"id":867062,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:09:18.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2410,"price":13.67,"value":32944.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":447436,"source":{"system":"sec-edgar","filing":"0001822014-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182201426000002/primarydocument.xml","form_type":"4"}},{"id":867061,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:09:18.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":23818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents vesting of performance-based restricted stock units."}],"balance_after":449846,"source":{"system":"sec-edgar","filing":"0001822014-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182201426000002/primarydocument.xml","form_type":"4"}},{"id":867060,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:09:18.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":11541,"price":13.75,"value":158688.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":426028,"source":{"system":"sec-edgar","filing":"0001822014-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182201426000002/primarydocument.xml","form_type":"4"}},{"id":867059,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:09:01.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":17755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents vesting of performance-based restricted stock units."}],"balance_after":192328,"source":{"system":"sec-edgar","filing":"0001917165-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000191716526000003/primarydocument.xml","form_type":"4"}},{"id":867960,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Medical and Innovation Ofr"}}],"security":"Ordinary Shares","published_at":"2026-03-03T16:11:29.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":3272,"price":13.3273,"value":43606.9256,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $13.31 USD to $13.36 USD; the price reported above reflects the weighted average sale price."}],"balance_after":223477,"source":{"system":"sec-edgar","filing":"0001811030-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000181103026000002/primarydocument.xml","form_type":"4"}},{"id":867959,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Medical and Innovation Ofr"}}],"security":"Ordinary Shares","published_at":"2026-03-03T16:11:29.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":12992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents vesting of performance-based restricted stock units."}],"balance_after":226749,"source":{"system":"sec-edgar","filing":"0001811030-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000181103026000002/primarydocument.xml","form_type":"4"}},{"id":867958,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62583,"kind":"person","name":"Weinberg Uri","position":1,"cik":"0001811030","reported_name":"Weinberg Uri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Medical and Innovation Ofr"}}],"security":"Ordinary Shares","published_at":"2026-03-03T16:11:29.000Z","date":"2026-02-27","kind":"sale","planned":false,"acquired":false,"shares":7461,"price":13.8395,"value":103256.5095,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.79 USD to $13.91 USD; the price reported above reflects the weighted average sale price."}],"balance_after":213757,"source":{"system":"sec-edgar","filing":"0001811030-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811030/000181103026000002/primarydocument.xml","form_type":"4"}},{"id":868897,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T16:10:09.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":408,"price":13.493,"value":5505.144,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $13.3126 USD to $13.70 USD; the price reported above reflects the weighted average sale price."}],"balance_after":76343,"source":{"system":"sec-edgar","filing":"0002039078-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907826000004/primarydocument.xml","form_type":"4"}},{"id":868896,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T16:10:09.000Z","date":"2026-02-27","kind":"sale","planned":false,"acquired":false,"shares":1555,"price":13.6638,"value":21247.209,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.45 USD to $13.97 USD; the price reported above reflects the weighted average sale price."}],"balance_after":76751,"source":{"system":"sec-edgar","filing":"0002039078-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907826000004/primarydocument.xml","form_type":"4"}},{"id":941243,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-12T17:30:38.000Z","date":"2026-01-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2133,"price":14.35,"value":30608.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":78306,"source":{"system":"sec-edgar","filing":"0002039078-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907826000002/primarydocument.xml","form_type":"4"}},{"id":943195,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-08T21:22:06.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":1,"price":10.99,"value":10.99,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2025 through December 31, 2025. This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2025."}],"balance_after":163763,"source":{"system":"sec-edgar","filing":"0001997032-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000199703226000001/primarydocument.xml","form_type":"5"}},{"id":943194,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33975,"kind":"person","name":"Danziger Asaf","position":1,"cik":"0001654435","reported_name":"Danziger Asaf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-08T21:21:49.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":1,"price":10.99,"value":10.99,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2025 through December 31, 2025. This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2025."}],"balance_after":416474,"source":{"system":"sec-edgar","filing":"0001654435-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000165443526000001/primarydocument.xml","form_type":"5"}},{"id":943193,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-01-08T21:21:25.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":108,"price":10.99,"value":1186.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2025 through December 31, 2025. This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2025."}],"balance_after":174573,"source":{"system":"sec-edgar","filing":"0001917165-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000191716526000001/primarydocument.xml","form_type":"5"}},{"id":1008128,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62544,"kind":"person","name":"Brackmann Christoph","position":1,"cik":"0002048634","reported_name":"Brackmann Christoph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-11-04T21:10:10.000Z","date":"2025-11-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":7033,"price":12.23,"value":86013.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":134117,"source":{"system":"sec-edgar","filing":"0002048634-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000204863425000004/primarydocument.xml","form_type":"4"}},{"id":1008127,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33977,"kind":"person","name":"Leonard Frank X","position":1,"cik":"0001822879","reported_name":"Leonard Frank X","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Pres., Novocure Oncology"}}],"security":"Ordinary Shares","published_at":"2025-11-04T21:09:29.000Z","date":"2025-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":966,"price":12.81,"value":12374.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":347745,"source":{"system":"sec-edgar","filing":"0001822879-25-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182287925000006/primarydocument.xml","form_type":"4"}},{"id":1008126,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2025-11-04T21:09:14.000Z","date":"2025-10-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":752,"price":12.82,"value":9640.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":163762,"source":{"system":"sec-edgar","filing":"0001997032-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000199703225000004/primarydocument.xml","form_type":"4"}},{"id":1008419,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2025-11-04T16:09:58.000Z","date":"2025-11-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2949,"price":12.23,"value":36066.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":80439,"source":{"system":"sec-edgar","filing":"0002039078-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907825000004/primarydocument.xml","form_type":"4"}},{"id":1008418,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2025-11-04T16:09:58.000Z","date":"2025-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":168,"price":12.81,"value":2152.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":83388,"source":{"system":"sec-edgar","filing":"0002039078-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907825000004/primarydocument.xml","form_type":"4"}},{"id":1045818,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-09-08T11:10:52.000Z","date":"2025-09-05","kind":"purchase","planned":false,"acquired":true,"shares":81550,"price":12.2239,"value":996859.045,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On the transaction date, the reporting person purchased 81,550 shares in multiple trades at prices ranging from $12.02 to $12.47.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide to the Staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":437569,"source":{"system":"sec-edgar","filing":"0001562180-25-006130","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025006130/primarydocument.xml","form_type":"4"}},{"id":1079082,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62544,"kind":"person","name":"Brackmann Christoph","position":1,"cik":"0002048634","reported_name":"Brackmann Christoph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-07-30T20:33:06.000Z","date":"2025-07-29","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":11.5,"value":57500.0,"ownership":{"direct":true},"balance_after":141150,"source":{"system":"sec-edgar","filing":"0001562180-25-005572","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025005572/primarydocument.xml","form_type":"4"}},{"id":1079081,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62544,"kind":"person","name":"Brackmann Christoph","position":1,"cik":"0002048634","reported_name":"Brackmann Christoph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-07-30T20:33:06.000Z","date":"2025-07-29","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":11.6,"value":58000.0,"ownership":{"direct":true},"balance_after":136150,"source":{"system":"sec-edgar","filing":"0001562180-25-005572","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025005572/primarydocument.xml","form_type":"4"}},{"id":1079080,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62544,"kind":"person","name":"Brackmann Christoph","position":1,"cik":"0002048634","reported_name":"Brackmann Christoph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-07-30T20:33:06.000Z","date":"2025-07-29","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":11.63,"value":116300.0,"ownership":{"direct":true},"balance_after":131150,"source":{"system":"sec-edgar","filing":"0001562180-25-005572","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025005572/primarydocument.xml","form_type":"4"}},{"id":1097824,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33978,"kind":"person","name":"Puri Michal Nath","position":1,"cik":"0001997032","reported_name":"Puri Michal Nath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Ordinary Shares","published_at":"2025-07-01T20:20:52.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":833,"price":15.13,"value":12603.29,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2025 through June 30, 2025.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2025."}],"balance_after":164514,"source":{"system":"sec-edgar","filing":"0001562180-25-005189","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025005189/primarydocument.xml","form_type":"4"}},{"id":1097823,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33977,"kind":"person","name":"Leonard Frank X","position":1,"cik":"0001822879","reported_name":"Leonard Frank X","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Pres., Novocure Oncology"}}],"security":"Ordinary Shares","published_at":"2025-07-01T20:19:49.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":833,"price":15.13,"value":12603.29,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2025 through June 30, 2025.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2025."}],"balance_after":348711,"source":{"system":"sec-edgar","filing":"0001562180-25-005188","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025005188/primarydocument.xml","form_type":"4"}},{"id":1097822,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33975,"kind":"person","name":"Danziger Asaf","position":1,"cik":"0001654435","reported_name":"Danziger Asaf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-07-01T20:19:41.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":833,"price":15.13,"value":12603.29,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2025 through June 30, 2025.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2025."}],"balance_after":416473,"source":{"system":"sec-edgar","filing":"0001562180-25-005187","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025005187/primarydocument.xml","form_type":"4"}},{"id":1097821,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-07-01T20:19:31.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":833,"price":15.13,"value":12603.29,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2025 through June 30, 2025.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2025."}],"balance_after":356019,"source":{"system":"sec-edgar","filing":"0001562180-25-005186","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025005186/primarydocument.xml","form_type":"4"}},{"id":1097820,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":33976,"kind":"person","name":"Ben Arye Barak","position":1,"cik":"0001917165","reported_name":"Ben Arye Barak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-07-01T20:19:22.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":769,"price":15.13,"value":11634.97,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2025 through June 30, 2025.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2025."}],"balance_after":174465,"source":{"system":"sec-edgar","filing":"0001562180-25-005185","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025005185/primarydocument.xml","form_type":"4"}},{"id":1119615,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40921,"kind":"person","name":"LEUNG GABRIEL","position":1,"cik":"0001236183","reported_name":"LEUNG GABRIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:21:51.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":16697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders."}],"balance_after":16697,"derivative":{"exercise_price":16.72,"exercise_date":"2026-06-04","expiration_date":"2035-06-04","underlying":"Ordinary Shares","underlying_shares":16697},"source":{"system":"sec-edgar","filing":"0001562180-25-004562","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025004562/primarydocument.xml","form_type":"4"}},{"id":1119614,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40921,"kind":"person","name":"LEUNG GABRIEL","position":1,"cik":"0001236183","reported_name":"LEUNG GABRIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-06T20:21:51.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":11215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders."}],"balance_after":92444,"source":{"system":"sec-edgar","filing":"0001562180-25-004562","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025004562/primarydocument.xml","form_type":"4"}},{"id":1119980,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":41004,"kind":"person","name":"Stafford Kristin","position":1,"cik":"0001970438","reported_name":"Stafford Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:20:45.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":16697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders."}],"balance_after":16697,"derivative":{"exercise_price":16.72,"exercise_date":"2026-06-04","expiration_date":"2035-06-04","underlying":"Ordinary Shares","underlying_shares":16697},"source":{"system":"sec-edgar","filing":"0001562180-25-004561","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1970438/000156218025004561/primarydocument.xml","form_type":"4"}},{"id":1119979,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":41004,"kind":"person","name":"Stafford Kristin","position":1,"cik":"0001970438","reported_name":"Stafford Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-06T20:20:45.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":11215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders."}],"balance_after":14269,"source":{"system":"sec-edgar","filing":"0001562180-25-004561","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1970438/000156218025004561/primarydocument.xml","form_type":"4"}},{"id":1119613,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:19:11.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":33393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders."}],"balance_after":33393,"derivative":{"exercise_price":16.72,"exercise_date":"2026-06-04","expiration_date":"2035-06-04","underlying":"Ordinary Shares","underlying_shares":33393},"source":{"system":"sec-edgar","filing":"0001562180-25-004560","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025004560/primarydocument.xml","form_type":"4"}},{"id":1119612,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":29474,"kind":"person","name":"HILLEMAN JERYL L","position":1,"cik":"0001216628","reported_name":"HILLEMAN JERYL L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:17:41.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":16697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders."}],"balance_after":16697,"derivative":{"exercise_price":16.72,"exercise_date":"2026-06-04","expiration_date":"2035-06-04","underlying":"Ordinary Shares","underlying_shares":16697},"source":{"system":"sec-edgar","filing":"0001562180-25-004559","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025004559/primarydocument.xml","form_type":"4"}},{"id":1119611,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":29474,"kind":"person","name":"HILLEMAN JERYL L","position":1,"cik":"0001216628","reported_name":"HILLEMAN JERYL L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-06T20:17:41.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":11215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders."}],"balance_after":16806,"source":{"system":"sec-edgar","filing":"0001562180-25-004559","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025004559/primarydocument.xml","form_type":"4"}},{"id":1119610,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40920,"kind":"person","name":"Ocean Allyson J","position":1,"cik":"0001967326","reported_name":"Ocean Allyson J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:16:49.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":16697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders."}],"balance_after":16697,"derivative":{"exercise_price":16.72,"exercise_date":"2026-06-04","expiration_date":"2035-06-04","underlying":"Ordinary Shares","underlying_shares":16697},"source":{"system":"sec-edgar","filing":"0001562180-25-004558","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025004558/primarydocument.xml","form_type":"4"}},{"id":1119609,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40920,"kind":"person","name":"Ocean Allyson J","position":1,"cik":"0001967326","reported_name":"Ocean Allyson J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-06T20:16:49.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":11215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders."}],"balance_after":14269,"source":{"system":"sec-edgar","filing":"0001562180-25-004558","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025004558/primarydocument.xml","form_type":"4"}},{"id":1119608,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":15597,"kind":"person","name":"Scannell Timothy J","position":1,"cik":"0001451533","reported_name":"Scannell Timothy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:15:40.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":16697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders."}],"balance_after":16697,"derivative":{"exercise_price":16.72,"exercise_date":"2026-06-04","expiration_date":"2035-06-04","underlying":"Ordinary Shares","underlying_shares":16697},"source":{"system":"sec-edgar","filing":"0001562180-25-004557","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025004557/primarydocument.xml","form_type":"4"}}],"next_cursor":"2025-06-06T20:15:40.000000Z,1119608"}